Advances in HFpEF Management (AHM)(CKM Navigation)
A Textbook of Cardiology
Published on 26. November 2024
Book
Hardback
1078 pages
978-93-6616-747-3 (ISBN)
Description
HFpEF, or Heart Failure with preserved ejection fraction, is a type of heart failure where the heart's main pumping chamber (the left ventricle) becomes too stiff to fill properly with blood, even though it can still contract normally. This leads to symptoms like breathlessness, fatigue, and swelling due to blood and fluid backing up in the lungs and body. HFpEF is often associated with other conditions such as high blood pressure, diabetes, obesity, and heart disease, and treatment focuses on managing these underlying factors and relieving symptoms.
Based on the experience of more than 300 contributors, this book is a comprehensive guide to the diagnosis and management of HFpEF, explaining advances in clinical approach, imaging including echocardiography, and multimodality imaging; and drug, mechanical and surgical interventions.
Comprising 21 sections and169 chapters, as many as 28 chapters in this book deal with echocardiography and HFpEF. Assessment of HFpEF using echocardiographic techniques such as three-dimensional echocardiography and more recent advances such as speckle tracking of echocardiography for assessment of left ventricular, left atrial, right ventricular, and right atrial strain, are covered in depth.
Discussion on echocardiographic ventricular and atrial remodeling reversal with various therapeutic agents, including sodium-glucose cotransporter-2 (SGLT2) inhibitors, angiotensin receptor-neprilysin inhibitor (ARNI), and bisoprolol, is included.
Exercise-induced left atrial hypertension in HFpEF and the effect of various therapeutic agents on left atrial stiffness index, left atrial function, and other left ventricular diastolic parameters are also examined.
Based on the experience of more than 300 contributors, this book is a comprehensive guide to the diagnosis and management of HFpEF, explaining advances in clinical approach, imaging including echocardiography, and multimodality imaging; and drug, mechanical and surgical interventions.
Comprising 21 sections and169 chapters, as many as 28 chapters in this book deal with echocardiography and HFpEF. Assessment of HFpEF using echocardiographic techniques such as three-dimensional echocardiography and more recent advances such as speckle tracking of echocardiography for assessment of left ventricular, left atrial, right ventricular, and right atrial strain, are covered in depth.
Discussion on echocardiographic ventricular and atrial remodeling reversal with various therapeutic agents, including sodium-glucose cotransporter-2 (SGLT2) inhibitors, angiotensin receptor-neprilysin inhibitor (ARNI), and bisoprolol, is included.
Exercise-induced left atrial hypertension in HFpEF and the effect of various therapeutic agents on left atrial stiffness index, left atrial function, and other left ventricular diastolic parameters are also examined.
More details
Language
English
Place of publication
New Delhi
India
Target group
Professional and scholarly
Dimensions
Height: 271 mm
Width: 223 mm
Thickness: 43 mm
Weight
2770 gr
ISBN-13
978-93-6616-747-3 (9789366167473)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
HK Chopra
Senior Consultant Cardiologist, Medanta - Moolchand Heart Institute, New Delhi, India; Chairman, CME, Moolchand Medcity; National Awardee, DST, Government of India; Chairman, World Wellness Foundation, WHA; Country Head, AHA; Former National President, CSI and IAE; Former National Editor-in-Chief, IHJ, JIAE; Editor-in-Chief, Top 14 Textbooks of Cardiology; Chief Advisor, Health Committee SCOPE
Navin C Nanda
Distinguished Professor, Department of Medicine and Cardiovascular Disease, University of Alabama at Birmingham, USA; Editor-in-Chief, Echocardiography: A Journal of Cardiovascular Ultrasound and Allied Techniques; President, International Society of Cardiovascular Ultrasound (ISCU)
Jagat Narula
Executive Vice President, Chief Academic Officer, UT Health Houston, Texas, USA; President, World Heart Federation
GS Wander
Professor and Head, Department of Cardiology, Dayanand Medical College and Hospital, Unit of Hero DMC Heart Institute, Ludhiana, Punjab, India; Past President, API
Sarita Bajaj
Senior Consultant Endocrinologist, Former Director-Professor and Head, Department of Medicine, MLN Medical College, Prayagraj, Uttar Pradesh, India
Viveka Kumar
Principal Director and Chief, Catheter Laboratories (Pan Max) - Cardiac Sciences, Max Super Speciality Hospital, Saket, New Delhi, India
Tiny Nair
Head, Department of Cardiology, PRS Hospital, Thiruvananthapuram, Kerala, India
CK Ponde
Chief, Non-invasive Cardiac Laboratory and Associate Director of Cardiac Catheter Laboratory, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India; Past President, IAE
AK Pancholia
Head, Department of Medicine, Clinical and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India
S Shanmugasundaram
Senior Consultant Cardiologist, Billroth Hospitals, Chennai, Tamil Nadu, India
Dinesh Khullar
Chairman and Head, Department Nephrology and Renal Transplant Medicine, Max Super Speciality Hospital, Saket, New Delhi, India
Satyendra Tewari
Department of Cardiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Senior Consultant Cardiologist, Medanta - Moolchand Heart Institute, New Delhi, India; Chairman, CME, Moolchand Medcity; National Awardee, DST, Government of India; Chairman, World Wellness Foundation, WHA; Country Head, AHA; Former National President, CSI and IAE; Former National Editor-in-Chief, IHJ, JIAE; Editor-in-Chief, Top 14 Textbooks of Cardiology; Chief Advisor, Health Committee SCOPE
Navin C Nanda
Distinguished Professor, Department of Medicine and Cardiovascular Disease, University of Alabama at Birmingham, USA; Editor-in-Chief, Echocardiography: A Journal of Cardiovascular Ultrasound and Allied Techniques; President, International Society of Cardiovascular Ultrasound (ISCU)
Jagat Narula
Executive Vice President, Chief Academic Officer, UT Health Houston, Texas, USA; President, World Heart Federation
GS Wander
Professor and Head, Department of Cardiology, Dayanand Medical College and Hospital, Unit of Hero DMC Heart Institute, Ludhiana, Punjab, India; Past President, API
Sarita Bajaj
Senior Consultant Endocrinologist, Former Director-Professor and Head, Department of Medicine, MLN Medical College, Prayagraj, Uttar Pradesh, India
Viveka Kumar
Principal Director and Chief, Catheter Laboratories (Pan Max) - Cardiac Sciences, Max Super Speciality Hospital, Saket, New Delhi, India
Tiny Nair
Head, Department of Cardiology, PRS Hospital, Thiruvananthapuram, Kerala, India
CK Ponde
Chief, Non-invasive Cardiac Laboratory and Associate Director of Cardiac Catheter Laboratory, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India; Past President, IAE
AK Pancholia
Head, Department of Medicine, Clinical and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India
S Shanmugasundaram
Senior Consultant Cardiologist, Billroth Hospitals, Chennai, Tamil Nadu, India
Dinesh Khullar
Chairman and Head, Department Nephrology and Renal Transplant Medicine, Max Super Speciality Hospital, Saket, New Delhi, India
Satyendra Tewari
Department of Cardiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Content
SECTION 1: HFpEF: CLINICAL SPECTRUM
SECTION 2: HFpEF AND DIAGNOSTIC BIOMARKERS
SECTION 3: HFpEF, ECHO AND IMAGING
SECTION 4: HFpEF AND CORONARY ARTERY DISEASE
SECTION 5: HFpEF AND ARRHYTHMIA
SECTION 6: HFpEF AND HYPERTENSION
SECTION 7: HFpEF AND PEDIATRICS
SECTION 8: HFpEF AND RENAL DISEASE
SECTION 10: HFpEF: CARDIO-OBSTETRICIAN AND GYNECOLOGY
SECTION 11: HFpEF: CARDIO-OPHTHALMOLOGY
SECTION 12: HFpEF AND CARDIODERMATOLOGY
SECTION 13: HFpEF, CARDIO-ENT AND CARDIOPULMONARY DISEASE
SECTION 14: HFpEF, CARDIODIABETES AND METABOLIC DISEASE
SECTION 15: HFpEF AND CARDIOLIPIDOLOGY
SECTION 16: HFpEF AND CARDIONUTRITION
SECTION 17: HFpEF AND CARDIO-ONCOLOGY
SECTION 18: HFpEF AND ECMO
SECTION 19: HFpEF AND THERAPEUTICS HFpEF and ARNI
SECTION 20: HFpEF AND REHABILITATION
SECTION 21: HFpEF AND FUTURE DIRECTION
SECTION 2: HFpEF AND DIAGNOSTIC BIOMARKERS
SECTION 3: HFpEF, ECHO AND IMAGING
SECTION 4: HFpEF AND CORONARY ARTERY DISEASE
SECTION 5: HFpEF AND ARRHYTHMIA
SECTION 6: HFpEF AND HYPERTENSION
SECTION 7: HFpEF AND PEDIATRICS
SECTION 8: HFpEF AND RENAL DISEASE
SECTION 10: HFpEF: CARDIO-OBSTETRICIAN AND GYNECOLOGY
SECTION 11: HFpEF: CARDIO-OPHTHALMOLOGY
SECTION 12: HFpEF AND CARDIODERMATOLOGY
SECTION 13: HFpEF, CARDIO-ENT AND CARDIOPULMONARY DISEASE
SECTION 14: HFpEF, CARDIODIABETES AND METABOLIC DISEASE
SECTION 15: HFpEF AND CARDIOLIPIDOLOGY
SECTION 16: HFpEF AND CARDIONUTRITION
SECTION 17: HFpEF AND CARDIO-ONCOLOGY
SECTION 18: HFpEF AND ECMO
SECTION 19: HFpEF AND THERAPEUTICS HFpEF and ARNI
SECTION 20: HFpEF AND REHABILITATION
SECTION 21: HFpEF AND FUTURE DIRECTION